What question did this study set out to answer?

To evaluate sexual function and aid use changes 12 months post-treatment for localized prostate cancer.

(117) Sexual Function, Bother and Aid Use in Patients Undergoing Curative Intended Treatment for Prostate Cancer Within a Global Registry

View Full Paper

Ask AI

Bookmark

To evaluate sexual function and aid use changes 12 months post-treatment for localized prostate cancer.
Utilized data from the TrueNTH Global Registry with over 200 institutions across 17 countries.
Included men diagnosed with localized or locally advanced prostate cancer from 2016 to 2022.
Conducted descriptive and comparative analyses with significance set at p<0.05.
Significant baseline differences in sexual function scores across treatment modalities (p<0.0001).
12-month follow-up showed 60% decline in sexual function after radical prostatectomy and 40% after brachytherapy.
Erectile function decline reported by up to 90% of RP patients; modest increases in aid use, especially in RP (+64.5%).

No takes yet. Share an insight, caveat, or question.

Randomized trial assesses sexual function changes after prostate cancer treatment, suggesting need for better support.

Hess et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark